Pharmaceutical patent analyst : Impact Factor & More
eISSN: 2046-8962pISSN: 2046-8954
Share this on:
Key Metrics
CiteScore 
3.7
H-Index
19
SJR
Q3Drug Discovery
SNIP
7.18
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Pharmaceutical patent analyst
Pharmaceutical patent analyst Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | NEWLANDS PRESS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmaceutical patent analyst ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Pharmaceutical patent analyst
Trispecific anti-CLDN-18.2/CD3/CD28 antibodies for gastric cancer treatment.
- 5 Aug 2025
- Pharmaceutical patent analyst
Bispecific anti-CD38/CD28 antibodies for treatment of multiple myeloma.
- 22 Jul 2025
- Pharmaceutical patent analyst
Trivalent bispecific anti-MSLN2/CD3 antibody for cancer treatment.
- 22 Jul 2025
- Pharmaceutical patent analyst
Proteolysis targeting chimeras (PROTACs) in oncology: a review of patents and regulatory considerations.
- 15 May 2025
- Pharmaceutical patent analyst
Development in medicinal chemistry via oxadiazole derivatives: patent spotlight 2020-2024.
- 7 May 2025
- Pharmaceutical patent analyst
Patent highlights June - July 2024.
- 7 Mar 2025
- Pharmaceutical patent analyst
Trispecific anti-CLDN-18.2/CD3/CD28 antibodies for gastric cancer treatment.
- 5 Aug 2025
- Pharmaceutical patent analyst
Bispecific anti-CD38/CD28 antibodies for treatment of multiple myeloma.
- 22 Jul 2025
- Pharmaceutical patent analyst
Trivalent bispecific anti-MSLN2/CD3 antibody for cancer treatment.
- 22 Jul 2025
- Pharmaceutical patent analyst
Proteolysis targeting chimeras (PROTACs) in oncology: a review of patents and regulatory considerations.
- 15 May 2025
- Pharmaceutical patent analyst
Development in medicinal chemistry via oxadiazole derivatives: patent spotlight 2020-2024.
- 7 May 2025
- Pharmaceutical patent analyst
Patent highlights June - July 2024.
- 7 Mar 2025
- Pharmaceutical patent analyst
FAQs on Pharmaceutical patent analyst
How long has Pharmaceutical patent analyst been actively publishing? 
What is the publishing frequency of Pharmaceutical patent analyst?
How many articles did Pharmaceutical patent analyst publish last year?
What is the eISSN & pISSN for Pharmaceutical patent analyst?
What is Citescore for Pharmaceutical patent analyst?
What is the H Index for Pharmaceutical patent analyst ?
What is SNIP score for Pharmaceutical patent analyst?
What is the SJR for Pharmaceutical patent analyst?
Who is the publisher of Pharmaceutical patent analyst?
